Wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Pharmacology Quiz

Total questions: 10

Worksheet time: 5mins

Name
Class
Date
1.

A drug has a volume of distribution (V_d) of 500 Liters in a 70kg man. This indicates that the drug is:

a)

Confined to the plasma compartment

b)

Highly bound to plasma albumin

c)

Extensively sequestered in peripheral tissues (e.g., fat or muscle)

d)

Excreted rapidly by the kidneys

2.

According to the Henderson-Hasselbalch principle, a weak acid drug (pKa = 3.5) will be most rapidly absorbed from the stomach (pH 1.5) because:

a)

It is predominantly in the ionized, water-soluble form

b)

It is predominantly in the non-ionized, lipid-soluble form

c)

The pH gradient favors active transport

d)

Weak acids are always absorbed faster than weak bases

3.

Which of the following best describes a "Partial Agonist" in the presence of a full agonist?

a)

It increases the V_{max} of the full agonist

b)

It acts as a competitive antagonist, reducing the overall maximal response

c)

It shifts the dose-response curve of the full agonist to the left

d)

It binds irreversibly to the receptor site

4.

The "Therapeutic Index" of a drug is a measure of its safety and is calculated as the ratio of:

a)

ED_{50} to LD_{50}

b)

LD_{50} to ED_{50}

c)

Clearance to Half-life

d)

Bioavailability to V_d

5.

In "First-Order Kinetics" of elimination:

a)

A constant amount of drug is eliminated per unit time

b)

The elimination rate is independent of plasma concentration

c)

A constant fraction of the drug is eliminated per unit time

d)

The half-life increases as the plasma concentration increases

6.

Which of the following physiological effects is mediated by the stimulation of M_3 Muscarinic receptors?

a)

Tachycardia

b)

Mydriasis (Pupillary dilation)

c)

Bronchoconstriction and increased glandular secretion

d)

Decreased gastrointestinal motility

7.

"Physostigmine" is clinically distinct from "Neostigmine" primarily because Physostigmine:

a)

Is a reversible cholinesterase inhibitor

b)

Is a quaternary ammonium compound that does not cross the Blood-Brain Barrier

c)

Is a tertiary amine that can cross the Blood-Brain Barrier to treat Atropine toxicity

d)

Has direct nicotinic agonist activity at the NMJ

8.

A patient is given an intravenous bolus of Epinephrine. Pre-treatment with which of the following drugs would cause "Epinephrine Reversal" (a decrease in blood pressure instead of an increase)?

a)

Propranolol (Beta-blocker)

b)

Phentolamine (Alpha-blocker)

c)

Atropine (Muscarinic blocker)

d)

Phenylephrine (Alpha-agonist)

9.

Which of the following is the "Rate-Limiting Step" in the biosynthesis of Catecholamines (Norepinephrine and Epinephrine)?

a)

Conversion of DOPA to Dopamine by Dopa-decarboxylase

b)

Hydroxylation of Tyrosine to DOPA by Tyrosine Hydroxylase

c)

Transport of Norepinephrine into storage vesicles

d)

Hydroxylation of Dopamine by Dopamine beta-hydroxylase

10.

"Pilocarpine" is primarily used in the treatment of Glaucoma because it:

a)

Causes paralysis of the ciliary muscle

b)

Produces mydriasis, opening the canal of Schlemm

c)

Produces miosis and contraction of the ciliary muscle, increasing aqueous outflow

d)

Inhibits the production of aqueous humor at the ciliary body